Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000590117 | SCV000697915 | benign | not provided | 2017-07-14 | criteria provided, single submitter | clinical testing | Variant summary: The LOX c.740+6G>A variant involves the alteration of a non-conserved intronic nucleotide. Mutation taster predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 188/120994 control chromosomes (1 homozygote) from ExAC, predominantly observed in the African subpopulation at a frequency of 0.012435 (129/10374). This frequency is about 746 times the estimated maximal expected allele frequency of a pathogenic LOX variant (0.0000167), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. To our knowledge, the variant of interest has not been published in affected individuals in literature. Taken together, this variant is classified as benign. |
Labcorp Genetics |
RCV000590117 | SCV001024926 | benign | not provided | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000590117 | SCV001794041 | likely benign | not provided | 2021-03-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000590117 | SCV005222860 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001729644 | SCV001977764 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001729644 | SCV001980356 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004735636 | SCV005344610 | benign | LOX-related disorder | 2024-06-03 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |